Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 17701
Country/Region: South Sudan
Year: 2018
Main Partner: Columbia University
Main Partner Program: International Center for AIDS Care and Treatment Programs
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $3,303,581 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $7,838
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $94,064
Care: Pediatric Care and Support (PDCS) $39,192
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Biomedical Prevention: Blood Safety (HMBL) $240,268
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $522,573
Sexual Prevention: Other Sexual Prevention (HVOP) $105,090
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $345,358
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $1,766,297
Treatment: Pediatric Treatment (PDTX) $182,901
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST <5, Unknown Sex, Negative 2019 297
HTS_TST 20-24, Male, Negative 2019 32
HTS_TST 25-29, Female, Negative 2019 33
HTS_TST 25-29, Female, Negative 2019 364
HTS_TST 25-29, Female, Negative 2019 7,650
HTS_TST 25-29, Female, Negative 2019 1,805
HTS_TST 25-29, Female, Negative 2019 2,526
HTS_TST 25-29, Female, Negative 2019 7
HTS_TST 25-29, Female, Negative 2019 1,801
HTS_TST 25-29, Male, Negative 2019 212
HTS_TST 25-29, Male, Negative 2019 4,873
HTS_TST 25-29, Male, Negative 2019 2,052
HTS_TST 25-29, Male, Negative 2019 814
HTS_TST 25-29, Male, Negative 2019 1,455
HTS_TST 30-34, Female, Negative 2019 255
HTS_TST 30-34, Female, Negative 2019 6,240
HTS_TST 30-34, Female, Negative 2019 2,292
HTS_TST 30-34, Female, Negative 2019 2,526
HTS_TST 30-34, Female, Negative 2019 811
HTS_TST 30-34, Female, Negative 2019 1,271
HTS_TST 30-34, Male, Negative 2019 156
HTS_TST 30-34, Male, Negative 2019 3,123
HTS_TST 30-34, Male, Negative 2019 961
HTS_TST 30-34, Male, Negative 2019 687
HTS_TST 30-34, Male, Negative 2019 430
HTS_TST 35-39, Female, Negative 2019 138
HTS_TST 35-39, Female, Negative 2019 951
HTS_TST 35-39, Female, Negative 2019 168
HTS_TST 35-39, Female, Negative 2019 415
HTS_TST 35-39, Male, Negative 2019 56
HTS_TST 35-39, Male, Negative 2019 850
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 85,934
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2019 844
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 830
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 1,534
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2019 5
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 65
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 57
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 11
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 120
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 44
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 293
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 171
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 6
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 25
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2019 194
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 1,905
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 340
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 292
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 2,088
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 817
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 4,635
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 1,813
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 380
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 212
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 73
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 113
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 111
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 1,004
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 754
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 1,264
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 1,550
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 239
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 252
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 849
HTS_TST Service Delivery Point (Facility) TB: <1, Negative 2019 19
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2019 396
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2019 65
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2019 86
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 93
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 166
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 141
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 393
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 123
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 292
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2019 4
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2019 85
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 133
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 178
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 371
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 327
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 1,304
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 1,014
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 272
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 185
HTS_TST Service Delivery Point (Facility)Other PITC: <1, Negative 2019 4
HTS_TST_POS <5, Unknown Sex, Positive 2019 21
HTS_TST_POS 20-24, Female, Positive 2019 6
HTS_TST_POS 20-24, Male, Positive 2019 6
HTS_TST_POS 25-29, Female, Positive 2019 52
HTS_TST_POS 25-29, Female, Positive 2019 487
HTS_TST_POS 25-29, Female, Positive 2019 109
HTS_TST_POS 25-29, Female, Positive 2019 77
HTS_TST_POS 25-29, Female, Positive 2019 93
HTS_TST_POS 25-29, Male, Positive 2019 36
HTS_TST_POS 25-29, Male, Positive 2019 349
HTS_TST_POS 25-29, Male, Positive 2019 167
HTS_TST_POS 25-29, Male, Positive 2019 129
HTS_TST_POS 25-29, Male, Positive 2019 80
HTS_TST_POS 30-34, Female, Positive 2019 27
HTS_TST_POS 30-34, Female, Positive 2019 438
HTS_TST_POS 30-34, Female, Positive 2019 131
HTS_TST_POS 30-34, Female, Positive 2019 77
HTS_TST_POS 30-34, Female, Positive 2019 129
HTS_TST_POS 30-34, Female, Positive 2019 47
HTS_TST_POS 30-34, Male, Positive 2019 6
HTS_TST_POS 30-34, Male, Positive 2019 236
HTS_TST_POS 30-34, Male, Positive 2019 60
HTS_TST_POS 30-34, Male, Positive 2019 109
HTS_TST_POS 30-34, Male, Positive 2019 31
HTS_TST_POS 35-39, Female, Positive 2019 6
HTS_TST_POS 35-39, Female, Positive 2019 99
HTS_TST_POS 35-39, Female, Positive 2019 3
HTS_TST_POS 35-39, Female, Positive 2019 14
HTS_TST_POS 35-39, Male, Positive 2019 4
HTS_TST_POS 35-39, Male, Positive 2019 46
HTS_TST_POS Service Delivery Point (Facility) ANC: 10-14, Positive 2019 26
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 26
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 47
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 19
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 15
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 43
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 23
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 33
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 23
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 32
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 31
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2019 26
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 122
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 59
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 354
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 137
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 17
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 16
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 68
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 29
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 97
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 91
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2019 24
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 17
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 48
HTS_TST_POS Service Delivery Point (Facility) TB: <1, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) TB: 1-9, Positive 2019 62
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Female, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Male, Positive 2019 12
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2019 13
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 26
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 19
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 61
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 17
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 46
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2019 8
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 13
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 16
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 32
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 43
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2019 7
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 4
PMTCT_ART Already on ART at beginning of current pregnancy 2019 76
PMTCT_ART New on ART 2019 304
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 380
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 8,819
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 247
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 165
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 412
PMTCT_EID Sum of Infant Age disaggregates 2019 412
PMTCT_STAT 25-29, Female 2019 4,390
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 57
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 4,184
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 149
PMTCT_STAT 30-34, Female 2019 1,857
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 57
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 1,769
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 33
PMTCT_STAT 35-39, Female 2019 12
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 6
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 2
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 4
PMTCT_STAT By Age (Numerator): 10-14 2019 86
PMTCT_STAT By Age (Numerator): 15-19 2019 853
PMTCT_STAT By Age (Numerator): 20-24 2019 1,592
PMTCT_STAT By Number of known positives: 15-19 2019 6
PMTCT_STAT By Number of known positives: 20-24 2019 16
PMTCT_STAT By Number of new negative: 10-14 2019 86
PMTCT_STAT By Number of new negative: 15-19 2019 831
PMTCT_STAT By Number of new negative: 20-24 2019 1,517
PMTCT_STAT By Number of new positives: 15-19 2019 14
PMTCT_STAT By Number of new positives: 20-24 2019 61
PMTCT_STAT Number of new ANC and L&D clients 2019 9,019
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 8,819
PMTCT_STAT_den 25-29, Female 2019 3,505
PMTCT_STAT_den 30-34, Female 2019 2,767
PMTCT_STAT_den 35-39, Female 2019 242
PMTCT_STAT_den By Age (Denominator): <15-19 2019 844
PMTCT_STAT_den By Age (Denominator): 10-14 2019 5
PMTCT_STAT_den By Age (Denominator): 20-24 2019 1,656
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 9
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 151
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 9
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 237
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 406
TB_PREV Alternative TPT Regimen, Life-long ART, Already, Positive 2019 9
TB_PREV Alternative TPT Regimen, Life-long ART, New, Positive 2019 281
TB_PREV By Age/Sex (Numerator): <15, Female 2019 9
TB_PREV By Age/Sex (Numerator): <15, Male 2019 140
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 281
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 506
TB_PREV IPT, Life-long ART, Already, Positive 2019 140
TB_PREV IPT, Life-long ART, New, Positive 2019 506
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 936
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 5,039
TB_PREV_den Alternative TPT Regimen, Life-long ART, Already, Positive 2019 31
TB_PREV_den Alternative TPT Regimen, Life-long ART, New, Positive 2019 936
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 31
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 468
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 936
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 1,684
TB_PREV_den IPT, Life-long ART, Already, Positive 2019 468
TB_PREV_den IPT, Life-long ART, New, Positive 2019 1,685
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 110
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 606
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 149
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 1,577
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 2,443
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 2,538
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 118
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 622
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 158
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 1,638
TX_CURR 25-29, Female, Positive 2019 3,226
TX_CURR 25-29, Male, Positive 2019 2,161
TX_CURR 30-34, Female, Positive 2019 1,916
TX_CURR 30-34, Male, Positive 2019 1,277
TX_CURR 35-39, Female, Positive 2019 639
TX_CURR 35-39, Male, Positive 2019 384
TX_CURR 40-49, Female, Positive 2019 575
TX_CURR 40-49, Male, Positive 2019 384
TX_CURR Age/Sex: <1 2019 118
TX_CURR Age/Sex: <1-9 2019 385
TX_CURR Age/Sex: 10-14 Female 2019 113
TX_CURR Age/Sex: 10-14 Male 2019 48
TX_CURR Age/Sex: 15-19 Female 2019 257
TX_CURR Age/Sex: 15-19 Male 2019 32
TX_CURR Age/Sex: 20-24 Female 2019 917
TX_CURR Age/Sex: 20-24 Male 2019 298
TX_CURR Age/Sex: 50+ Female 2019 236
TX_CURR Age/Sex: 50+ Male 2019 492
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 13,458
TX_CURR Sum of age/sex disaggregates 2019 289
TX_NEW 25-29, Female, Positive 2019 930
TX_NEW 25-29, Male, Positive 2019 795
TX_NEW 30-34, Female, Positive 2019 455
TX_NEW 30-34, Male, Positive 2019 313
TX_NEW 35-39, Female, Positive 2019 499
TX_NEW 35-39, Male, Positive 2019 239
TX_NEW 40-49, Female, Positive 2019 148
TX_NEW 40-49, Male, Positive 2019 107
TX_NEW Breastfeeding status 2019 41
TX_NEW By Age/Sex: <1 2019 20
TX_NEW By Age/Sex: 1-9 2019 30
TX_NEW By Age/Sex: 10-14 Female 2019 148
TX_NEW By Age/Sex: 10-14 Male 2019 14
TX_NEW By Age/Sex: 15-19 Female 2019 44
TX_NEW By Age/Sex: 15-19 Male 2019 29
TX_NEW By Age/Sex: 20-24 Female 2019 361
TX_NEW By Age/Sex: 20-24 Male 2019 274
TX_NEW By Age/Sex: 50+ Female 2019 130
TX_NEW By Age/Sex: 50+ Male 2019 137
TX_NEW MSM 2019 2
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 4,673
TX_NEW Pregnancy status 2019 536
TX_NEW Sum of Age/Sex disaggregates 2019 1,137
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 11,343
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 227
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 113
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 5,671
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 5,331
TX_PVLS_den Denominator: Indication: Routine 2019 11,343
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 102
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 86
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 1,751
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 982
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 2,939
TX_RET Numerator by Status: Breastfeeding 2019 148
TX_RET Numerator by Status: Pregnant 2019 118
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 3,280
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 104
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 93
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 1,911
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 1,133
TX_RET_den Denominator by Status: Breastfeeding 2019 58
TX_RET_den Denominator by Status: Pregnant 2019 138
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 9,163
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2019 301
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2019 9
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2019 9
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2019 114
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2019 169
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 169
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 179
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2019 3,977
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2019 4,837
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 4,464
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 4,699
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 9,163
TX_TB_den Life-long ART, Already, TB Screen - Negative, Positive 2019 6,405
TX_TB_den Life-long ART, Already, TB Screen - Positive, Positive 2019 926
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 1,602
TX_TB_den Life-long ART, New, TB Screen - Positive, Positive 2019 230